Gland Pharma Ltd
NSE:GLAND
Gland Pharma Ltd
NSE:GLAND
Price:
1 871.6
INR
-0.74%
Market Cap:
₹308.4B
Relative Value
The Relative Value of one
GLAND
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 1 871.6 INR,
Gland Pharma Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
GLAND Relative Value
HIDDEN
Multiples Across Competitors
GLAND Competitors Multiples
Gland Pharma Ltd Competitors
Gland Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Gland Pharma Ltd
NSE:GLAND
|
308.4B INR | 5.1 | 36.6 | 19.1 | 26.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
973.8B USD | 14.9 | 47.2 | 31.8 | 33.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.5B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
277B CHF | 4.6 | 29.8 | 12.6 | 14.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
233.5B CHF | 5.3 | 21.5 | 13.3 | 17.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
219.8B GBP | 5.3 | 32.8 | 15.6 | 22.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
292.2B USD | 4.5 | 16 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD | 2.5 | 20.3 | 7.5 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.8B USD | 2.6 | 17.5 | 6.9 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
